Consolidated Balance Sheets - USD ($) $ in Millions	May 31, 2023	Feb. 28, 2023
Current
Cash and cash equivalents (note 2)	$ 358	$ 295
Short-term Investments	158	131
Accounts Receivable, after Allowance for Credit Loss, Current	117	120
Other receivables (note 3)	8	12
Income taxes receivable	3	3
Other current assets (note 3)	52	182
Assets, Current, Total	696	743
Restricted cash and cash equivalents (note 2)	27	27
Long-term investments (note 2)	35	34
Other long-term assets (note 3)	60	8
Operating Lease, Right-of-Use Asset	44	44
Property, plant and equipment, net (note 3)	24	25
Goodwill (note 3)	596	595
Intangible assets, net (note 3)	192	203
Assets	1,674	1,679
Current
Accounts payable	21	24
Accrued liabilities (note 3)	128	143
Income taxes payable (note 4)	21	20
Debentures (note 5)	389	367
Deferred revenue, current (note 10)	177	175
Total current liabilities	736	729
Deferred revenue, non-current (note 10)	26	40
Operating lease liabilities	52	52
Other long-term liabilities	1	1
Total liabilities	815	822
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable	0	0
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 583,237,331 voting common shares (February 28, 2023 - 582,157,203)	2,920	2,909
Deficit	(2,039)	(2,028)
Accumulated other comprehensive loss (note 8)	(22)	(24)
Total shareholders' equity	859	857
Total liabilities and shareholders' equity	$ 1,674	$ 1,679
Common issued (in shares)	583,237,331	582,157,203
Common outstanding (in shares)	583,237,331	582,157,203